
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from gastric juice that promotes tissue healing through enhanced angiogenesis and growth factor activation. This peptide accelerates recovery of muscles, tendons, ligaments and gastrointestinal tissue by stimulating VEGF production and collagen synthesis.

Reported Benefits (Provisional)
Origin & History

BPC-157 is a synthetic peptide derived from a protein found in gastric juice. It is produced through peptide synthesis techniques that ensure high purity and bioavailability for therapeutic use.
Research Narrative (Provisional)
Animal studies and preliminary human research suggest BPC-157's efficacy in tissue repair and inflammation reduction. More clinical trials are required to confirm these benefits in humans.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Composed of 15 amino acids. - Contains no calories, fats, or carbohydrates. - Available in injectable or oral forms.
Reported Mechanism (Provisional)
BPC-157 activates the growth hormone receptor and stimulates production of vascular endothelial growth factor (VEGF), promoting new blood vessel formation. The peptide enhances collagen type I and III synthesis while modulating the FAK-paxillin pathway, which regulates cell migration and tissue repair. It also influences the nitric oxide pathway and activates the VEGFR2-Akt-eNOS signaling cascade to improve blood flow to injured tissues.
Clinical Narrative (Provisional)
Most BPC-157 research consists of animal studies showing significant healing improvements in tendon, muscle and gastric injuries. Limited human studies include small trials (20-40 participants) demonstrating potential benefits for inflammatory bowel conditions, with one study showing 77% improvement in ulcerative colitis symptoms. Dosages in human trials ranged from 10-20 mcg/kg body weight daily. The evidence base remains preliminary as large-scale randomized controlled trials in humans are lacking.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







